ASJA JAMES

Allopathic & Osteopathic Physicians|Urology MELROSE, MA NPI 1780359059

General Payments — all program years on this page

$1,485.18

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,108.45 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,108.4522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $47.362
2022 $138.734
2023 $190.647
2024 $1,108.4522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078696933 Janssen Biotech, Inc. $144.15 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078696940 Janssen Biotech, Inc. $31.84 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078696953 Janssen Biotech, Inc. $1.18 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078696980 Janssen Biotech, Inc. $80.01 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078696985 Janssen Biotech, Inc. $28.25 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078696997 Janssen Biotech, Inc. $35.65 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078697001 Janssen Biotech, Inc. $103.40 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078697009 Janssen Biotech, Inc. $38.06 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078697028 Janssen Biotech, Inc. $3.17 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078697059 Janssen Biotech, Inc. $122.50 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393613 ABBVIE INC. $31.35 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393615 ABBVIE INC. $30.84 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393617 ABBVIE INC. $31.80 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393619 ABBVIE INC. $33.66 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393621 ABBVIE INC. $21.51 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107393623 ABBVIE INC. $25.35 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125508214 IMMUNITYBIO, INC. $31.63 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141562042 Merck Sharp & Dohme LLC $24.13 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141823817 Merck Sharp & Dohme LLC $28.96 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144031070 PROCEPT BioRobotics Corporation $194.60 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148969667 Sumitomo Pharma America, Inc. $36.54 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151367447 180 Medical, Inc. $29.87 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.